1. Home
  2. JWEL vs GLTO Comparison

JWEL vs GLTO Comparison

Compare JWEL & GLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JWEL
  • GLTO
  • Stock Information
  • Founded
  • JWEL 2012
  • GLTO 2011
  • Country
  • JWEL China
  • GLTO Denmark
  • Employees
  • JWEL N/A
  • GLTO N/A
  • Industry
  • JWEL Other Consumer Services
  • GLTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • JWEL Consumer Discretionary
  • GLTO Health Care
  • Exchange
  • JWEL Nasdaq
  • GLTO Nasdaq
  • Market Cap
  • JWEL 3.8M
  • GLTO 4.5M
  • IPO Year
  • JWEL 2021
  • GLTO 2020
  • Fundamental
  • Price
  • JWEL $1.81
  • GLTO $18.03
  • Analyst Decision
  • JWEL
  • GLTO Buy
  • Analyst Count
  • JWEL 0
  • GLTO 1
  • Target Price
  • JWEL N/A
  • GLTO $10.00
  • AVG Volume (30 Days)
  • JWEL 25.1K
  • GLTO 6.9M
  • Earning Date
  • JWEL 05-09-2025
  • GLTO 10-31-2025
  • Dividend Yield
  • JWEL N/A
  • GLTO N/A
  • EPS Growth
  • JWEL N/A
  • GLTO N/A
  • EPS
  • JWEL N/A
  • GLTO N/A
  • Revenue
  • JWEL $132,981,531.00
  • GLTO N/A
  • Revenue This Year
  • JWEL N/A
  • GLTO N/A
  • Revenue Next Year
  • JWEL N/A
  • GLTO N/A
  • P/E Ratio
  • JWEL N/A
  • GLTO N/A
  • Revenue Growth
  • JWEL N/A
  • GLTO N/A
  • 52 Week Low
  • JWEL $1.45
  • GLTO $2.01
  • 52 Week High
  • JWEL $3.71
  • GLTO $31.70
  • Technical
  • Relative Strength Index (RSI)
  • JWEL 44.17
  • GLTO 93.65
  • Support Level
  • JWEL $1.70
  • GLTO $3.64
  • Resistance Level
  • JWEL $1.78
  • GLTO $4.13
  • Average True Range (ATR)
  • JWEL 0.11
  • GLTO 1.51
  • MACD
  • JWEL 0.00
  • GLTO 1.07
  • Stochastic Oscillator
  • JWEL 40.00
  • GLTO 60.67

About JWEL Jowell Global Ltd.

Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing. Geographically, it generates all of its revenue from the PRC.

About GLTO Galecto Inc.

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Share on Social Networks: